i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Male patients require higher optimal effect-site concentrations of propofol during i-gel insertion with dexmedetomidine 0.5 μg/kg

Choi JJ, Kim JY, Lee D, Chang YJ, Cho NR, Kwak HJ. BMC Anesthesiol. 2016 Mar 22;16:20

40 patients were split into equal gender groups prior to insertion. The EC50 of propofol in men was approximately 40% higher than in women. Gender should be considered when determining optimal dose of propofol, according to the authors.

Link to abstract

Pressure support ventilation with the I-gel in intensive care unit: case report

Akan B, Erdem D, Albayrak MD, Aksoy E, Akdur F, Gogus N. Braz J Anesthesiol. 2016;66(2):219-21

This case report described the use of the i-gel for the management of ventilation in an ICU patient. A 49-year-old woman was hospitalized in ICU due to fever and respiratory distress. Three intubations using a bougie failed, but the airways were subsequently secured with an i-gel (size 3) at the first attempt. No issues were seen in mechanical ventilation using the i-gel for 48 hours in pressure-controlled ventilation. Thus, the i-gel can be used in difficult intubation scenarios, allowing mechanical ventilation up to 48 hours.

Link to abstract

The association between thenar eminence and i-gel dimensions in paediatric patients

Cuvas Apan O, Apan A. Rev Bras Anestesiol. 2016;66(2):171-5

270 patients aged 0-12 years not requiring tracheal intubation were recruited. After induction, thenar eminence dimensions were measured and compared with the patient's inserted i-gel. Authors conclude their results showed that the dimensions of thenar eminence fitted the weight-based size selection of i-gel, and that it could be a practical way to choose the correct size device.

Link to abstract

Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of out of hospital cardiac arrest (REVIVE-Airways): a feasibility study

Benger J, Coates D, Davies S, Greenwood R, Nolan J, Rhys M, Thomas M, Voss S. Br J Anaesth. 2016;116(2):262-8

A cluster randomised trial of paramedics within one ambulance service in England over a 12-month period, split into groups using either the i-gel or LMA Supreme or usual practice for all patients with non-traumatic adult OHCA. Primary outcome was study feasibility, including recruitment and protocol adherence. Secondary outcomes included survival to hospital discharge and to 90 days. 184 of 535 paramedics consented, with 615 patients recruited. The LMA Supreme arm was suspended following 'adverse incidents'. No differences were reported in secondary outcomes.

Link to abstract